Published online by Cambridge University Press: 06 March 2019
In its most recent term, the United States Supreme Court heard a case arising out of the activities of a price-fixing cartel in the vitamins market. The defendants were a number of major international pharmaceuticals companies, including F. Hoffman-LaRoche, Rhone-Poulenc, Daiichi Pharmaceutical, and BASF, that had fixed prices for bulk vitamins and vitamin pre-mixes in markets around the world. The cartel, which has been described as “probably the most economically damaging cartel ever prosecuted under U.S. antitrust law,” is estimated to have affected over $5 billion of commerce worldwide. Previous proceedings against the participants in the cartel, initiated in Australia, Canada and the European Union as well as in the United States, included administrative investigations and criminal prosecutions of individual executives. In these various proceedings, the cartel participants were found to have violated antitrust laws in the United States and elsewhere, and were subjected to heavy – indeed, record – fines in many countries. By all accounts, the countries engaged in investigating and then prosecuting the cartel participants did so in full cooperation with each other. In particular, they made use of the mutual assistance and information sharing agreements that have become an important component of coordinated international antitrust enforcement.
1 F. Hoffman-LaRoche Ltd. v. Empagran S.A., 124 S.Ct. 2359, 159 L.Ed.2d 226 (2004).Google Scholar
2 124 S.Ct. at 2363.Google Scholar
3 Harry First, The Vitamins Case: Cartel Prosecutions and the Coming of International Competition Law, 68 Antitrust Law Journal 711, 712 (2001). See also EU Fines Eight Companies For Roles in Vitamin Cartels, 81 Antitrust & Trade Regulation Reports (BNA) 483, 483 quoting Mario Monti, who described it as “the most damaging series of cartels the [European C]ommission has ever investigated.”Google Scholar
4 See First, supra note 3, at 715-19 for a description of the various penalties assessed against cartel participants.Google Scholar
5 For instance, both the Chairman of the Australian Competition and Consumer Commission and a spokesman for the European Commission mentioned cooperation with the U.S. authorities as part of their investigative efforts. See 76 Antitrust & Trade Regulation Reports (BNA) 585, 586 (1999).Google Scholar
6 124 S.Ct. at 2363-64. Domestic purchasers of the vitamins had consolidated their claims into a separate lawsuit.Google Scholar
7 Empagran S.A. v. F. Hoffman-LaRoche Ltd., 315 F.3d 338 (D.C. Cir. 2003).Google Scholar
8 Such briefs were filed by the governments of Belgium, Canada, Germany, Ireland, Japan, the Netherlands, and the United Kingdom. All are available in the Briefs file on WESTLAW.Google Scholar
9 See, e.g., Brief of the Governments of the Federal Republic of Germany and Belgium as Amici Curiae in Support of Petitioners at 2, 7.Google Scholar
10 See, e.g., Brief for the Government of Canada as Amicus Curiae Supporting Reversal at 14.Google Scholar
11 See, e.g., Otto Graf Lambsdorff, Wettbewerbsrecht als Ordnungsfaktor einer globalisierten Marktwirtschaft, 7/8 Wirtschaft und Wettbewerb 710 (2003).Google Scholar
12 See Brief Amici Curiae of Legal Scholars in Support of Respondents at 12. This argument played a significant role in the court below. The Court of Appeals had noted the following:Google Scholar
We are persuaded that, if foreign plaintiffs could not enforce the antitrust laws with respect to the foreign effects of anticompetitive behavior, global conspiracy would be under-deterred, since the perpetrator might well retain the benefits that the conspiracy accrued abroad. There would be an incentive to engage in global conspiracies, because, even if the conspirator has to disgorge his U.S. profits in suits by domestic plaintiffs, he would very possibly retain his foreign profits, which may make up for his U.S. liability.Google Scholar
315 F.3d at 356. This point had been made by the Supreme Court itself in an earlier case addressing the ability of foreign governments to assert private antitrust claims in U.S. courts. See Pfizer, Inc. v. Government of India, 434 U.S. 308, 315 (1978).Google Scholar
13 See Brief of Amici Curiae Economists Joseph E. Stiglitz and Peter R. Orszag in Support of Respondents at 8-12; Brief for Certain Professors of Economics as Amici Curiae in Support of Respondents 5-12.Google Scholar
14 See Brief of Joseph E. Stiglitz and Peter R. Orszag, supra note 13, at 12.Google Scholar
15 For a discussion of the FTAIA generally, see IA Phillip E. Areeda and Herbert Hovencamp, Antitrust Law ¶ 272 (2d ed. 2000).Google Scholar
16 15 U.S.C. §6A (2001).Google Scholar
17 315 F.3d at 344.Google Scholar
18 Den Norske Stats Oljeselskap A.S. v. Heeremac V.O.F., 241 F.3d 420 (5th Cir. 2001) [hereinafter “Statoil“].Google Scholar
19 Id. at 426.Google Scholar
20 Id. at 427.Google Scholar
21 Kruman v. Christie's Int'l PLC, 284 F.3d 384 (2d. Cir. 2002).Google Scholar
22 Id. at 389.Google Scholar
23 Id.Google Scholar
24 Id. at 399-400.Google Scholar
25 315 F.3d 338.Google Scholar
26 Id. at 350. The precise test adopted in Empagran varied slightly from that adopted by the Second Circuit. The Kruman court held that “the ‘effect’ on domestic commerce need not be the basis for a plaintiff's injury, it only must violate the substantive provisions of the Sherman Act.” 284 F.3d at 400. The Empagran court, on the other hand, held that the effects of the conduct “must give rise to ‘a claim’ by someone, even if not the foreign plaintiff who is before the court.” 315 F.3d at 350. This view is slightly more restrictive in that it requires that the conduct be sufficient to give rise to a private claim; creating the basis for a government action would not be sufficient. Id.Google Scholar
27 As I have argued elsewhere, it is possible to imagine an intermediate interpretation of the FTAIA – one that recognizes the regulatory interests of the United States, but counsels jurisdictional restraint when another nation in fact has a competing interest. See Hannah L. Buxbaum, Jurisdictional Conflict in Global Antitrust Enforcement, 16 Loyola Consumer Law Review 365, 367-72 (2004). Such a view would recognize the distinction between countries that do in fact prosecute cartels and those that do not. On this point, see also Ralf Michaels & Daniel Zimmer, US-Gerichte als Weltkartellgerichte?, IPRax (2004 forthcoming); Fox, Eleanor, International Antitrust and the Doha Dome, 43 Virginia Journal of International Law 911, 923 (2003).Google Scholar
28 124 S.Ct. at 2363.Google Scholar
29 The decision was 8-0, with Justice O'Connor taking no part in the consideration or decision of the case.Google Scholar
30 124 S.Ct. at 2366.Google Scholar
31 124 S.Ct. at 2369.Google Scholar
32 124 S.Ct. at 2366.Google Scholar
33 Id.Google Scholar
34 See OECD Council Recommendation Concerning Effective Action Against Hard-Core Cartels, C(98)/35/FINAL, 25 March 1998, available at www.oecd.org/document.Google Scholar
35 124 S.Ct. at 2368.Google Scholar
36 This has been a particular point of conflict in international antitrust cases. See Hannah L. Buxbaum, The Private Attorney General in a Global Age: Public Interests in Private Antitrust Litigation, 26 Yale Journal of International Law 251-53 (2001). Other elements of the U.S. system that are questioned abroad include the use of class actions and contingency fee arrangements to support private litigation under regulatory laws.Google Scholar
37 See supra note 8.Google Scholar
38 124 S.Ct. at 2368. This section also addresses the concern that specific programs granting amnesty to whistle-blowers would be disrupted by the availability of private actions – a point in which the U.S. government concurred. See Brief for the United States as Amicus Curiae Supporting Petitioners at 19-21.Google Scholar
39 124 S.Ct. at 2366 (emphasis added).Google Scholar
40 124 S.Ct. at 2367.Google Scholar
41 See further discussion of this point in Part IV below.Google Scholar
42 See, e.g., Spencer Weber Waller, The Twilight of Comity, 38 Columbia Journal of Transnational Law 563 (2000).Google Scholar
43 509 U.S. 764 (1993).Google Scholar
44 Id. at 797.Google Scholar
45 Id. at 798, citing Société Nationale Industrielle Aérospatiale v. United States District Court, 482 U.S. 522, 555 (1987) (Blackmun, J., concurring in part and dissenting in part).Google Scholar
46 Id. at 799.Google Scholar
47 Id.Google Scholar
48 124 S.Ct. at 2366.Google Scholar
49 This distinction, reflected in the Restatement (Third) of the Foreign Relations Law of the United States, was the subject of dispute in Hartford Fire. Justice Scalia, in his dissent in that case, characterized the issue as one of prescriptive jurisdiction; the majority, as one of subject-matter jurisdiction. See 509 U.S. at 813-15 (Scalia, J., dissenting). The Empagran opinion in fact cites that very dissent; see 124 S.Ct. at 2366. Further to the distinction between prescriptive jurisdiction and subject-matter jurisdiction, and its relevance in international antitrust cases, see Michaels & Zimmer, supra note 27.Google Scholar
50 509 U.S. at 820 (Scalia, J., dissenting).Google Scholar
51 124 S.Ct. at 2369.Google Scholar
52 At one point, the Court states this explicitly: “[W]e reemphasize that we base our decision upon the following: … the adverse foreign effect is independent of any adverse domestic effect.” Id. at 2366.Google Scholar
53 See Areeda and Hovencamp, supra note 15, at ¶ 273.Google Scholar
54 124 S.Ct. at 2366 (emphasis in original). Interestingly, the Court here cites only the 1945 decision in United States v. Aluminum Co. of America, 148 F.2d 416, which itself predated the development of interest balancing and other comity-driven tests.Google Scholar
55 124 S.Ct. at 2372.Google Scholar
56 Id.Google Scholar
57 Id. The foreign plaintiffs in the other global cartel cases made similar claims. In Statoil, the plaintiffs argued that “because the defendants operating in the Gulf of Mexico were able to maintain their monopolistic pricing only because of their overall market allocation scheme …, Statoil's injury in the North Sea was a ‘necessary prerequisite to’ and was ‘the quid pro quo for’ the injury suffered in the United States domestic market.” 241 F.3d at 425. In Kruman, too, the plaintiffs argued that “the domestic price-fixing agreement could only have succeeded with the foreign price-fixing agreement.” 284 F.3d at 401. This interdependence was also stressed in the briefs of economists supporting U.S. jurisdiction in Empagran. See, e.g., Brief for Certain Professors of Economics, supra note 14, at 5-7 (discussing the connections between effects on U.S. and foreign commerce in cartels affecting mobile products).Google Scholar
58 If, as the Supreme Court notes, they properly preserved that argument. 124 S.Ct. at 2372.Google Scholar
59 At the least, the lack of connections to the United States would suggest the greater likelihood of dismissal on the basis of forum non conveniens. See Buxbaum, supra note 27, at 374.Google Scholar
60 124 S.Ct. at 2370-71.Google Scholar
61 124 S.Ct. at 2369.Google Scholar
62 Id.Google Scholar
63 See discussion of these cases at 124 S.Ct. at 2369-70.Google Scholar
64 124 S.Ct. at 2370.Google Scholar
65 See Buxbaum, supra note 36, at 222-225.Google Scholar
66 124 S.Ct. at 2370 [internal citation omitted]. This argument has been used in the past to support the notion that courts should apply comity analysis in private claims.Google Scholar
67 See supra notes 12-14 and accompanying text.Google Scholar
68 124 S.Ct. at 2372.Google Scholar
69 124 S.Ct. at 2368-69.Google Scholar
70 124 S.Ct. at 2372.Google Scholar
71 See Fox, supra note 27.Google Scholar